期刊文献+

肝硬化和肝癌组织中乙型肝炎病毒、丙型肝炎病毒及p53蛋白的检测 被引量:1

Measurement hepatitis B,C virus and p53 protein in cirrhosis and hepatocellular carcinoma
下载PDF
导出
摘要 目的检测肝硬化和肝细胞癌(hepatocellular carcinoma,HCC)组织中乙型肝炎(hepatitis B virus,HBV)表面抗原(HBsAg)、丙型肝炎(hepatitis C virus,HCV)核心抗原(HCVAg)和p53蛋白的表达。方法应用免疫组织化学法检测20例肝硬化,78例HCC及癌旁肝组织HBsAg、HCVAg和p53蛋白的表达。结果肝硬化,HCC及癌旁肝组织中HBsAg、HCVAg、HBsAg并HCVAg和p53蛋白表达率分别为75.0%、40.0%、25.0%2、0.0%;9.07%、6.4%、2.6%、87.2%;80.8%、44.9%、29.5%、21.8%,3组间有显著性差异(P<0.01)。HCC与癌旁肝组织之间HBsAg、HCVAg、HBsAg并HCVAg和p53蛋白阳性表达率有显著性差异(P<0.01)。在肝硬化和HCC无肝硬化组,p53蛋白表达与HBsAg阳性率显著相关(P<0.01)。HCC合并肝硬化组p53蛋白表达与HBsAg、HCVAg、HBsAg并HCVAg阳性率显著相关(P<0.01)。结论HCC的发生与HBV和HCV的感染密切相关,肝细胞癌变是一个长期的、多因素作用的结果,在这个过程中p53基因的突变起到了重要的作用。 Objective To detect Hitching, HCVAg and p53 protein in cirrhosis and HCC. Methods Immunohistoclacmical method was used to detect HBsAg, HCVAg and p53 protein in 20 cirrbosis, 78 HCC and paracarcincma hepatic tissues. Results The positive expressions of HBsAg, HCAVg,HBsAg with HCVAg, and p53 protein in cirrhosis, HCC and paracarcinoma hepatic tissues were 75.0%, 40.0%, 25.0%, 20.0% ; 9.0%, 6.4%, 2.6%, 87.2% ; 80.8%, 44.9%, 29.5%, 21.8% respectively, with significant difference (P〈0.01) among three groups.There has significant difference(P〈0.01) between HCC and paracarcincma hepatic tissue.The positive expression of p53 protein was closely related to that of HBsAg in cirrhosis and HCC without cirrhosis ( P〈0.01). The positive expression of p53 protein was strongly liked to that of HBsAg, HCVAg, HBsAg with HCVAg in HCC with cirrhosis ( P〈0.01). Conclusion HBV and HCV are strongly liked to HCC. Hepatocarcinogenesis is a long process relating to many factors. This result shows that mutation of p53 gene plays a important role in this process.
出处 《宁夏医学杂志》 CAS 2005年第9期585-587,共3页 Ningxia Medical Journal
关键词 乙型肝炎病毒 丙型肝炎病毒 P53蛋白 肝细胞癌 肝硬化 Hepatitis B virus Hapatitis C virus P53 protein Hepatocellular carcinoma Cirrhosis
  • 相关文献

参考文献9

  • 1朱忠政,丛文铭.乙型肝炎病毒和丙型肝炎病毒在肝癌发生中的作用研究进展[J].中华肝脏病杂志,2003,11(9):574-576. 被引量:28
  • 2Kew M C.Hepatitis B and C virus and hepatocellular carcinoma[J].Clin Lab Med,2002,16:395-406.
  • 3Kumar V,Cotran R S,Robbins R S. Basic Pathology,7th edition[M].北京:北京大学医学院出版社,2003,601-605.
  • 4Shin W L,Kuo M L,Chuang S E,et al. Hepatitis B virus X protein inhibitis transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway[J]. J Biol Chem, 2000,275:25858-25864.
  • 5Koike K,Tsutsumi T,Fujie H, et al. Molecular mechanism of viral hepatocarcinogenesis[J]. Oncology, 2002,62:29-37.
  • 6陆东东.肝癌易感状态及其与癌前病变关系[J].医师进修杂志,2004,27(3):6-8. 被引量:3
  • 7Trevisani F,Cantarini MC,Labate AM,et al.Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival[J].Am J Gastroenterol,2004,99:1470-1476.
  • 8Ray RB,Steele R,Meyer K,et al.Transcriptional repression of gene p53 promoter by hepatitis C virus core protein[J].J Biol Chem,1997,272:10983-10986.
  • 9Fettelson MA,Zhu M H,Duan L X,et al.Hepatitis B X antigen and p53 are Hepatocellular carcinoma[J].Oncogene,2002,22:1109-1117.

二级参考文献30

  • 1Koike K, Tsutsumi T, Fujie H, et al. Molecular mechanism of viral hepatocarcinogenesis. Oncology, 2002, 62: 29-37.
  • 2Lee SG, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene, 2000, 19: 468-471.
  • 3Ray RB, Steele R, Meyer K, et al. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem, 1997, 272:10983-10986.
  • 4Wang F, Yoshida I, Takamatsu M, et al. Complex formation between hepatitis C virus core protein and p21Wafl/Cipl/Sdil.Biochem Biophys Res Commun, 2000, 273: 479-484.
  • 5Tai DI, Tsai SL, Chen YM, et al. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology, 2000, 31: 656-664.
  • 6Ruggieri A, Harada T, Matsuura Y, et al. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology, 1997,229: 68-76.
  • 7Aoki H, Hayashi J, Moriyama M, et al. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol, 2000, 74: 1736-1741.
  • 8Kwun HJ, Jung EY, Ahn JY, et al. p53-dependent transcriptional repression of p21(wafl) by hepatitis C virus NS3. J Gen Virol, 2001,82: 2235-2241.
  • 9Kato N, Lan KH, Ono-Nita SK, et al. Hepatitis c virus nonstructural region 5A protein is a potent transcriptional activator. J Virol,1997, 71: 8856-8859.
  • 10Majumder M, Ghosh AK, Steele R, et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology, 2002, 294: 94-105.

共引文献28

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部